M&A Deal Summary |
|
|---|---|
| Date | 2015-08-24 |
| Target | Cytovance Biologics |
| Sector | Life Science |
| Buyer(s) | Shenzhen Hepalink Pharmaceutical Group |
| Sellers(s) |
Great Point Partners
Monroe Capital |
| Deal Type | Add-on Acquisition |
| Deal Value | 206M USD |
| Advisor(s) | Wells Fargo Securities (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Life Science |
| Employees | 2,080 |
| Revenue | 5.4B CNY (2023) |
Shenzhen Hepalink Pharmaceutical Group has been a leading global supplier of high quality active pharmaceutical ingredients (APIs) for nearly four decades. SPL specializes in cGMP biopharmaceutical manufacturing and is one of the largest commercial suppliers of Heparin Sodium USP, Pancreatin USP, and Pancrelipase USP. SPL serves the pharmaceutical, veterinary, and food industries globally, and has a manufacturing facility located in Waunakee, Wisconsin as well as a facility in Sioux City, Iowa. Shenzhen Hepalink Pharmaceutical Group was founded in 1998 and is based in Shenzhen, China.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector (Life Science) | 2 of 2 |
| Type (Add-on Acquisition) | 2 of 2 |
| State (Oklahoma) | 1 of 1 |
| Country (United States) | 2 of 2 |
| Year (2015) | 1 of 1 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-04-17 |
Scientific Protein Laboratories
Waunakee, Wisconsin, United States Scientific Protein Laboratories LLC is a global independent manufacturer and supplier of biologic active pharmaceutical ingredients (APIs). The company has an established bio pharmaceutical companies around the world. |
Buy | $338M |
| Category | Private Equity Firm |
|---|---|
| Founded | 2003 |
| PE ASSETS | 1.7B USD |
| Size | Large |
| Type | Sector Focused |
Great Point Partners is a private investment firm focused on investing in private and public healthcare companies. Great Point's private equity practice invests $10 to $100 million of growth capital in private, growing companies. Specific areas of interest within the healthcare sector includes biotechnology and life sciences, consumer health, generic drugs, health care services, information technology, insurance, medical devices, specialty pharmaceuticals, and worker compensation companies. Great Point Partners was formed in 2003 and is based in Greenwich, Connecticut.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 18 |
| Sector (Life Science) | 3 of 7 |
| Type (Add-on Acquisition) | 2 of 7 |
| State (Oklahoma) | 1 of 1 |
| Country (United States) | 4 of 14 |
| Year (2015) | 1 of 3 |
| Size (of disclosed) | 3 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-03-09 |
MaSTherCell SA
Gosselies, Belgium MaSTherCell SA (Manufacturing Synergies for Therapeutic Cells) is a technology-driven, customer-oriented Contract Development and Manufacturing Organization (CDMO) specialized in cell therapy development for advanced medicinal products. MaSTherCell was established in 2011 and is based in Gosselies, Belgium. |
Buy | $25M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-11-05 |
iVantage
Portland, Maine, United States iVantage is a provider of health care informatics and business analytics solutions that transform complex data into actionable business intelligence. This platform is used by hospital management teams to drive empirical and evidence based decision making. These tools are positioned at the center of a large market opportunity due to increased demand for meaningful data driven by new compliance based requirements and operational challenges of the Patient Protection and Affordable Care Act. iVantage was founded in 2011 and is based in Portland, Maine. |
Sell | - |
| Category | Lender |
|---|---|
| Founded | 2004 |
| PE ASSETS | 14.1B USD |
| Size | Mega |
| Type | Sector Agnostic |
Monroe Capital is a provider of senior and junior debt and equity co-investments to middle-market companies in the US and Canada. Investment types include unitranche financings, cash flow and enterprise value based loans, asset based loans, acquisition facilities, mezzanine debt, second lien or last-out loans and equity co-investments. Monroe Capital is a generalist investor and will consider companies in the healthcare, technology, media, retail, consumer sectors. Monroe Capital was formed in 2004 and is based in Chicago.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 53 |
| Sector (Life Science) | 1 of 2 |
| Type (Add-on Acquisition) | 6 of 27 |
| State (Oklahoma) | 1 of 1 |
| Country (United States) | 10 of 53 |
| Year (2015) | 3 of 5 |
| Size (of disclosed) | 4 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-08-18 |
Channel
Minnetonka, Minnesota, United States Channel is a provider of equipment finance and working capital solutions through partnerships with equipment finance companies. Channel products and services utilize customized technology and business processes to help these companies provide their customers access to broader financing options and capital needed to grow their businesses. Channel was founded in 2009 and is based in Minnetonka, Minnesota. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-09-23 |
Autotronic Controls
El Paso, Texas, United States Autotronic Controls Corp. is a designer, developer and manufacturer of automotive products including ignition controls, fuel injection systems, coils, timing accessories, spark plug wires and accessories. |
Sell | - |
